Cargando…
EE564 Study on the Value Pricing of COVID-19 Vaccine in China Based on the Evidence of Cost-Effectiveness Analysis
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256526/ http://dx.doi.org/10.1016/j.jval.2023.03.2542 |
| _version_ | 1785057123464380416 |
|---|---|
| author | Fu, Y. Zhao, J. Han, P. Yang, L. Ren, T. Zhan, S. Li, L. |
| author_facet | Fu, Y. Zhao, J. Han, P. Yang, L. Ren, T. Zhan, S. Li, L. |
| author_sort | Fu, Y. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10256526 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102565262023-06-12 EE564 Study on the Value Pricing of COVID-19 Vaccine in China Based on the Evidence of Cost-Effectiveness Analysis Fu, Y. Zhao, J. Han, P. Yang, L. Ren, T. Zhan, S. Li, L. Value Health Article Elsevier 2023-06 2023-06-10 /pmc/articles/PMC10256526/ http://dx.doi.org/10.1016/j.jval.2023.03.2542 Text en Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Fu, Y. Zhao, J. Han, P. Yang, L. Ren, T. Zhan, S. Li, L. EE564 Study on the Value Pricing of COVID-19 Vaccine in China Based on the Evidence of Cost-Effectiveness Analysis |
| title | EE564 Study on the Value Pricing of COVID-19 Vaccine in China Based on the Evidence of Cost-Effectiveness Analysis |
| title_full | EE564 Study on the Value Pricing of COVID-19 Vaccine in China Based on the Evidence of Cost-Effectiveness Analysis |
| title_fullStr | EE564 Study on the Value Pricing of COVID-19 Vaccine in China Based on the Evidence of Cost-Effectiveness Analysis |
| title_full_unstemmed | EE564 Study on the Value Pricing of COVID-19 Vaccine in China Based on the Evidence of Cost-Effectiveness Analysis |
| title_short | EE564 Study on the Value Pricing of COVID-19 Vaccine in China Based on the Evidence of Cost-Effectiveness Analysis |
| title_sort | ee564 study on the value pricing of covid-19 vaccine in china based on the evidence of cost-effectiveness analysis |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256526/ http://dx.doi.org/10.1016/j.jval.2023.03.2542 |
| work_keys_str_mv | AT fuy ee564studyonthevaluepricingofcovid19vaccineinchinabasedontheevidenceofcosteffectivenessanalysis AT zhaoj ee564studyonthevaluepricingofcovid19vaccineinchinabasedontheevidenceofcosteffectivenessanalysis AT hanp ee564studyonthevaluepricingofcovid19vaccineinchinabasedontheevidenceofcosteffectivenessanalysis AT yangl ee564studyonthevaluepricingofcovid19vaccineinchinabasedontheevidenceofcosteffectivenessanalysis AT rent ee564studyonthevaluepricingofcovid19vaccineinchinabasedontheevidenceofcosteffectivenessanalysis AT zhans ee564studyonthevaluepricingofcovid19vaccineinchinabasedontheevidenceofcosteffectivenessanalysis AT lil ee564studyonthevaluepricingofcovid19vaccineinchinabasedontheevidenceofcosteffectivenessanalysis |